偶然分枝杆菌和龟分枝杆菌五个亚组的抗菌药敏性
Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae.
作者信息
Swenson J M, Wallace R J, Silcox V A, Thornsberry C
出版信息
Antimicrob Agents Chemother. 1985 Dec;28(6):807-11. doi: 10.1128/AAC.28.6.807.
Abstract
Broth microdilution MICs were determined for 258 clinical isolates of Mycobacterium fortuitum (3 biovariants) and M. chelonae (2 subspecies) with amikacin, tobramycin, cefoxitin, doxycycline, erythromycin, and sulfamethoxazole-trimethoprim and with several new beta-lactams and aminoglycosides and ciprofloxacin. Variations in susceptibility by and within species subgroups confirm the need for susceptibility testing against clinically important strains.
摘要
采用肉汤微量稀释法测定了258株偶然分枝杆菌（3个生物变种）和龟分枝杆菌（2个亚种）临床分离株对阿米卡星、妥布霉素、头孢西丁、强力霉素、红霉素、磺胺甲恶唑-甲氧苄啶以及几种新型β-内酰胺类、氨基糖苷类和环丙沙星的最低抑菌浓度（MIC）。种内和种间亚组药敏性的差异证实了针对临床重要菌株进行药敏试验的必要性。
相似文献
1
Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae.偶然分枝杆菌和龟分枝杆菌五个亚组的抗菌药敏性
Antimicrob Agents Chemother. 1985 Dec;28(6):807-11. doi: 10.1128/AAC.28.6.807.
2
Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.脓肿分枝杆菌、龟分枝杆菌和偶发分枝杆菌肉汤微量稀释法药敏试验结果的多中心可重复性。
J Clin Microbiol. 1999 Jun;37(6):1676-82. doi: 10.1128/JCM.37.6.1676-1682.1999.
3
[Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].[龟分枝杆菌和脓肿分枝杆菌的药敏分析及Etest药敏试验评估]
Zhonghua Jie He He Hu Xi Za Zhi. 2013 Aug;36(8):567-71.
4
In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.伊朗非结核分枝杆菌的体外抗菌药敏性
Microb Drug Resist. 2016 Mar;22(2):172-8. doi: 10.1089/mdr.2015.0134. Epub 2015 Oct 15.
5
Multisite reproducibility of Etest for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.用于脓肿分枝杆菌、龟分枝杆菌和偶发分枝杆菌药敏试验的Etest的多中心再现性。
J Clin Microbiol. 2000 Feb;38(2):656-61. doi: 10.1128/JCM.38.2.656-661.2000.
6
[Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].[快速生长分枝杆菌的抗菌药敏性评估]
Mikrobiyol Bul. 2023 Apr;57(2):220-237. doi: 10.5578/mb.20239917.
7
In Vitro activities of isepamicin, other aminoglycosides, and capreomycin against clinical isolates of rapidly growing mycobacteria in Taiwan.异帕米星、其他氨基糖苷类药物及卷曲霉素对台湾快速生长分枝杆菌临床分离株的体外活性
Antimicrob Agents Chemother. 2007 May;51(5):1849-51. doi: 10.1128/AAC.01551-06. Epub 2007 Mar 12.
8
9
Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution.快速生长分枝杆菌：采用肉汤微量稀释法检测对34种抗菌药物的敏感性
Antimicrob Agents Chemother. 1982 Aug;22(2):186-92. doi: 10.1128/AAC.22.2.186.
10
In vitro activity of the new quinolone RO 23-6240 (AM-833) and the new cephalosporins RO 15-8074 and RO 19-5247 (T-2525) against Mycobacterium fortuitum and Mycobacterium chelonae.新型喹诺酮RO 23-6240（AM-833）以及新型头孢菌素RO 15-8074和RO 19-5247（T-2525）对偶然分枝杆菌和龟分枝杆菌的体外活性
Eur J Clin Microbiol. 1987 Aug;6(4):487-8. doi: 10.1007/BF02013118.
引用本文的文献
1
Aminoglycosides-Related Ototoxicity: Mechanisms, Risk Factors, and Prevention in Pediatric Patients.氨基糖苷类药物相关耳毒性：小儿患者的机制、危险因素及预防
Pharmaceuticals (Basel). 2023 Sep 25;16(10):1353. doi: 10.3390/ph16101353.
2
Antimicrobial Resistance in Rapidly Growing Nontuberculous Mycobacteria among Domestic and Wild Animals Emphasizing the Zoonotic Potential.家畜和野生动物中快速生长非结核分枝杆菌的抗菌药物耐药性：强调人畜共患病潜力
Microorganisms. 2023 Oct 9;11(10):2520. doi: 10.3390/microorganisms11102520.
3
Mab2780c, a TetV-like efflux pump, confers high-level spectinomycin resistance in mycobacterium abscessus.Mab2780c 是一种 TetV 样外排泵，可赋予脓肿分枝杆菌高水平的大观霉素耐药性。
Tuberculosis (Edinb). 2023 Jan;138:102295. doi: 10.1016/j.tube.2022.102295. Epub 2022 Dec 22.
4
Mycobacterium abscessus HelR interacts with RNA polymerase to confer intrinsic rifamycin resistance.耻垢分枝杆菌HelR 与 RNA 聚合酶相互作用赋予固有利福霉素耐药性。
Mol Cell. 2022 Sep 1;82(17):3166-3177.e5. doi: 10.1016/j.molcel.2022.06.034. Epub 2022 Jul 28.
5
Pharmacologic Management of Infections: A Primer for Clinicians.感染的药物治疗：临床医生入门指南
Open Forum Infect Dis. 2022 Jun 15;9(7):ofac287. doi: 10.1093/ofid/ofac287. eCollection 2022 Jul.
6
Antibiotic Susceptibility of Mycobacteria Isolated from Ornamental Fish.从观赏鱼中分离出的分枝杆菌的抗生素敏感性
J Vet Res. 2022 Mar 25;66(1):69-76. doi: 10.2478/jvetres-2022-0011. eCollection 2022 Mar.
7
A first case report of nasopharyngeal Mycobacterium abscessus subspecies massiliense infection.首例鼻咽部脓肿分枝杆菌亚种马萨利ensis 感染的病例报告。
Eur J Med Res. 2021 Sep 18;26(1):109. doi: 10.1186/s40001-021-00578-8.
8
Prevalence of non tuberculous mycobacterial infection in surgical site infections and their antibiotic susceptibility profile.手术部位感染中非结核分枝杆菌感染的患病率及其抗生素敏感性概况。
Med J Armed Forces India. 2021 Jul;77(3):343-348. doi: 10.1016/j.mjafi.2020.01.012. Epub 2020 May 4.
9
A Series of Tattoo-associated Infections.一系列与纹身相关的感染
J Clin Aesthet Dermatol. 2021 Apr;14(4):38-40. Epub 2021 Apr 1.
10
The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex.亚胺培南-克拉霉素联合用药对脓肿分枝杆菌复合体的协同作用。
BMC Microbiol. 2020 Oct 19;20(1):316. doi: 10.1186/s12866-020-02000-5.
本文引用的文献
1
Sulfonamide activity against Mycobacterium fortuitum and Mycobacterium chelonei.磺胺对偶然分枝杆菌和龟分枝杆菌的活性。
Rev Infect Dis. 1981 Sep-Oct;3(5):898-904. doi: 10.1093/clinids/3.5.898.
2
Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei.阿米卡星和多西环素治疗偶然分枝杆菌和龟分枝杆菌感染的临床效用。
Rev Infect Dis. 1981 Sep-Oct;3(5):1068-74. doi: 10.1093/clinids/3.5.1068.
3
In vitro susceptibility of mycobacterium fortuitum and mycobacterium chelonei to cefoxitin.偶然分枝杆菌和龟分枝杆菌对头孢西丁的体外敏感性
Tubercle. 1982 Jun;63(2):125-7. doi: 10.1016/s0041-3879(82)80049-4.
4
In vitro activity of trimethoprim and sulfamethoxazole against the nontuberculous mycobacteria.甲氧苄啶和磺胺甲恶唑对非结核分枝杆菌的体外活性。
Rev Infect Dis. 1982 Mar-Apr;4(2):326-31. doi: 10.1093/clinids/4.2.326.
5
Identification of clinically significant Mycobacterium fortuitum complex isolates.具有临床意义的偶然分枝杆菌复合群菌株的鉴定。
J Clin Microbiol. 1981 Dec;14(6):686-91. doi: 10.1128/jcm.14.6.686-691.1981.
6
In vitro susceptibility of Mycobacterium fortuitum to N-formimidoyl thienamycin and several cephamycins.偶然分枝杆菌对N-甲酰亚胺基硫霉素及几种头孢霉素的体外敏感性
Antimicrob Agents Chemother. 1982 Dec;22(6):1079-81. doi: 10.1128/AAC.22.6.1079.
7
Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution.快速生长分枝杆菌：采用肉汤微量稀释法检测对34种抗菌药物的敏感性
Antimicrob Agents Chemother. 1982 Aug;22(2):186-92. doi: 10.1128/AAC.22.2.186.
8
In vitro susceptibility of Mycobacterium fortuitum and M. chelonei to sisomicin, gentamicin and tobramycin.偶然分枝杆菌和龟分枝杆菌对西索米星、庆大霉素和妥布霉素的体外敏感性
Ann Microbiol (Paris). 1983 Nov-Dec;134B(3):451-4.
9
Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics.用于海分枝杆菌和偶然分枝杆菌复合群对磺胺类药物及抗生素药敏试验的琼脂纸片洗脱法
Antimicrob Agents Chemother. 1983 Oct;24(4):486-93. doi: 10.1128/AAC.24.4.486.
10
In vitro susceptibility of Mycobacterium fortuitum to amoxicillin or cephalothin in combination with clavulanic acid.偶然分枝杆菌对阿莫西林或头孢噻吩与克拉维酸联合用药的体外敏感性。
Antimicrob Agents Chemother. 1983 Jun;23(6):935-7. doi: 10.1128/AAC.23.6.935.
Zotero 插件